Ardent Health Partners LLC

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ardent Health Partners, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals, through its subsidiaries. The company was founded in 1993 and is headquartered in Nashville, TN.

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that nine of its facilities earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety. Leapfrog assigns an “A,” “B,” “C,” “D” or “F” grade to general hospitals across the country based on over 30 performance measures reflecting errors, accidents, injuries and i.

Nine Ardent Health Facilities Earn “A” Hospital Safety Grade From The Leapfrog Group

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the third quarter ended September 30, 2024. Third Quarter 2024 Operating and Financial Summary All comparisons are versus the same prior year period, unless otherwise noted. See the footnotes to the Operating Statistics table of this press release for definitions of th.

Ardent Health Reports Third Quarter 2024 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that members of the Company's management team will participate in the following upcoming investor conferences: Stephens Annual Investment Conference on Tuesday, November 19, in Nashville, Tennessee. Members of the management team will participate in a fireside chat discussion at 10:00 a.m. ET that same day. Citi 2024 Global Healthc.

Ardent Health to Participate in Upcoming Investor Conferences

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced it will issue its third quarter 2024 results after the market closes on Wednesday, November 6, 2024. A conference call will be held the following day, Thursday, November 7, 2024, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference ca.

Ardent Health Announces Third Quarter 2024 Results Conference Call and Webcast Date

NEW YORK--(BUSINESS WIRE)--Qventus, an industry titan in AI-based software that automates care operations, announced today that Ardent Health, a leading provider of healthcare services in communities across the country, has chosen Qventus' Perioperative Solution to optimize its robotics program and drive strategic surgical growth. The unique solution optimizes surgeries by intelligently marketing operating room (OR) time to surgeons based on strategic objectives and personalized surgeon pattern.

Ardent Health Partners With Qventus to Drive Strategic Perioperative Growth

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) has been added as a member of the broad-market Russell 3000® Index and Russell 2000®, effective Monday, September 23, 2024, as part of the quarterly U.S. Russell Index Initial Public Offering (IPO) update. “We are pleased to join the Russell 3000® Index and look forward to building awareness around the Ardent growth story while increasing our exposure to new investor audiences,” said Ardent President and Chief Executive Officer Marty.

Ardent Health Added to Russell 2000® and 3000® Indexes

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced it has entered into an amendment to its term loan credit agreement with its lenders to reprice its term loans. The repricing reduces the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 3.25% to Term SOFR plus 2.75%, as well as eliminates the credit spread adjustment. There are no changes to the maturity of the loans following the repricing and all other terms are subs.

Ardent Health Completes Term Loan Repricing

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent's investor relations program and serve as the primary liaison with investors, analysts and financial partners. Styblo brings more than 20 years of investment experience, including time as a sell-side analyst covering the healthcare industry. He previously served as a senior vice president at Jeffe.

Ardent Health Appoints Dave Styblo to Lead Investor Relations

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference being held September 4-6, 2024, in New York, NY. Ardent Health President and Chief Executive Officer Marty Bonick and Chief Financial Officer Alfred Lumsdaine will take part in a fireside c.

Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Summary (All comparisons versus the same prior year period, unless otherwise noted) Total revenue of $1.47 billion, an increase of 7.5% Net income of $67 million Net income attributable to Ardent Hea.

Ardent Health Reports Second Quarter 2024 Results

In July, Ardent Health Partners Inc. ARDT closed its initial public offering of 12 million at a public offering price of $16 per share, for total gross proceeds of approximately $192 million.

New Hospital Operator On The Block Ardent Health Garners Interest As Analysts Initiate With Bullish View

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that it will issue its second quarter 2024 results after the market closes on Wednesday, August 14, 2024. A conference call will be held the following day, Thursday, August 15, 2024, at 10:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a ques.

Ardent Health Announces Second Quarter 2024 Results Conference Call and Webcast Date

Actuate Therapeutics Inc

Artiva Biotherapeutics Inc

Bloomz Inc

Concentra Group Holdings Parent Inc

Lineage Inc

Latam Airlines Group SA

Onestream Inc

QMMM Holdings Ltd

TWFG Inc

Viking Holdings Ltd

A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group. Six IPOs are scheduled to list in the week ahead and are set to raise a combined $5.1 billion, the most for any week so far this year. One SPAC is also set to debut.

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (NYSE: ARDT) (f/k/a Ardent Health Partners, LLC and collectively “Ardent Health” or the “Company”), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced the closing of its initial public offering (the “Offering”) of 12,000,000 shares of its common stock sold by the Company at a public offering price of $16 per share, for total gross proceeds of approximately $192 million, before ded.

Ardent Health Announces Closing of Its Initial Public Offering

Healthcare provider Ardent Health's shares opened 6% below their initial public offering price in their NYSE debut on Thursday, reflecting new investor caution with new listings amid rate cut uncertainties.

Ardent Health falls 6% in lukewarm NYSE debut

Another high-profile healthcare-related IPO is taking place this week. Here's what you ned to know about Ardent Health Partners and its initial public offering:

Ardent Health IPO: Stock price today as hospitals and healthcare provider debuts on the NYSE

Healthcare provider Ardent Health said on Wednesday it has set the pricing of its initial public offering below its targeted range to raise around $192 million.

Ardent Health prices US IPO below target range to raise $192 mln

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC and collectively, “Ardent Health”) today announced the pricing of its initial public offering of 12,000,000 shares of its common stock at a price to the public of $16 per share. In connection with the offering, Ardent Health granted the underwriters a 30-day option to purchase up to an additional 1,800,000 shares of common stock at the initial public offering price, less the underwriting discounts.

Ardent Health Announces Pricing of Initial Public Offering

Two SPACs debuted this week, and one company completed an uplisting from the OTC. Meanwhile, three IPOs and two SPACs submitted initial filings this past week. After a quiet post-holiday week, the July IPO market is set to bag its first major deals in the week ahead. Street research is expected for one company in the week ahead, and one lock-up period will be expiring.

U.S. IPO Weekly Recap: 2 SPACs Debut In Quiet Post-Holiday Week

Healthcare provider Ardent Health is targeting a valuation of about $3.15 billion in its initial public offering, it said on Monday, as the U.S. capital market continues to run hot by attracting new entrants.

Ardent Health targets valuation of about $3.15 billion in US IPO

Lionheart Holdings

Flag Ship Acquisition Corp

Landbridge Co LLC

Rectitude Holdings Ltd

One IPO and three SPACs debuted this week. Singapore-based safety equipment provider Rectitude Holdings priced at the bottom of the range to raise $8 million at a $58 million market cap. Three IPOs are currently scheduled to debut in the week ahead as the second quarter comes to a close.

U.S. IPO Weekly Recap: Flurry Of SPACs And IPOs Fill The Pipeline In Short Holiday Week

Hospital operator Ardent Health Partners, which is backed by an investment firm founded by the late real-estate magnate Sam Zell, has filed for a initial public offering, according to regulatory documents submitted Friday.

News for Ardent Health Partners LLC Stock (ARDT)